Main > A1. CORP. INDEX. A-Am No. 1 > Actinium Pharmaceuticals Inc./P C2



Actinium Pharmaceuticals Inc./P C2's subsections
2012. 07.11. Fred Hutchinson
2012. 07.25. Onco.>AML
2012. 08.09. Philogen SPA.
2013. 01.03. Goes Public
2013. 05.13. USA Patent
2015. 06.24. Files Prov Patent APP.
2016. 03.08. Files Prov Patent APP.
2016. 07.12. USA Patent
2018. 03.28. Astellas Pharma
2021. 12.14. R/R AML Actimab-A+C
2021. 12.14. R/R AML Actimab-A+V
2022. 01.05. EpicentRx
2022. 02.22. AVEO Oncology
2022. 04.11. HER3 MAb-Ac-225
2022. 04.11. HER3 MAb-Ac-225+
2022. 04.12. Iomab-B Immedica
2022. 04.19. Iomab-B
2022. 04.25. Iomab-B
Web-Site

Actinium Pharmaceuticals Inc./P C2's products
This section has no products